Company profile: 4G Clinical
1.1 - Company Overview
Company description
- Provider of software and services for clinical drug trials focused on randomization and trial supply management (RTSM), offering Prancer RTSM for complex and simple study randomization and supply, 4C Supply to manage supply chain risks, project patient demand, and adapt to protocol amendments, and Prancer RTSM Rand-Only for randomization-only patient tracking with blinded/unblinded site users.
Products and services
- 4C Supply: A protocol-adaptive tool that enables clinical supply managers to mitigate supply chain risks, project patient demand, and adjust to protocol amendments
- Prancer RTSM: A configurable system that administers randomization and trial supply in clinical trials, supporting complex protocol designs as well as simpler studies
- Prancer RTSM Rand-Only: A blinding-compatible module that simplifies patient tracking for studies requiring only randomization, supporting both blinded and unblinded site users
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to 4G Clinical
XtalPi
HQ: United States
Website
- Description: Provider of integrated digital drug discovery and development solutions combining AI, cloud computing, and wet lab validation. Offerings include ID4 platform, AI + physics-based models to predict drug-like properties, synthetic chemistry services with the XtalDynamics automation system, XupremAb biologics discovery, and targeted libraries of drug-like molecules.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full XtalPi company profile →
Transition Bio
HQ: United States
Website
- Description: Provider of condensate technology for drug discovery and diagnostics, offering PhaseScanTM, a microfluidics-based high-throughput molecular screen to identify drug candidates and mechanisms of action; CelPhaseTM, high-content cellular imaging to visualize condensates in disease models and patient samples for target validation; and DeePhaseTM, an AI engine using proprietary datasets for target discovery and hit identification.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Transition Bio company profile →
Valo Health
HQ: United States
Website
- Description: Provider of AI-driven therapeutics discovery and development solutions leveraging large-scale human data. Offerings include the Opal computational platform to identify and validate drug targets and enable small-molecule discovery; Target Discovery using machine learning and biomarkers; Logica, an integrated solution with Charles River Laboratories; and OPL-0401, an investigational ROCK1/2 inhibitor for diabetic retinopathy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Valo Health company profile →
Terray Therapeutics
HQ: United States
Website
- Description: Provider of a small molecule drug discovery platform (tNova) integrating chemical experimentation and computation, using ultra-dense microarrays to generate interaction datasets and machine learning to map biochemical interactions. Also develops an internal immunology pipeline for small molecule therapeutics and partners with pharma and biotech across therapeutic areas.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Terray Therapeutics company profile →
BioAge Labs
HQ: United States
Website
- Description: Provider of clinical-stage therapeutics for obesity, metabolic, and neurodegenerative diseases. Offers Azelaprag, an oral APJ agonist to enhance weight loss and improve body composition alongside incretin drugs; BGE-100, a CNS-penetrant NLRP3 inhibitor targeting neuroinflammation; and a discovery platform analyzing multi-omics to identify aging and disease mediators and new drug targets.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioAge Labs company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for 4G Clinical
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to 4G Clinical
2.2 - Growth funds investing in similar companies to 4G Clinical
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for 4G Clinical
4.2 - Public trading comparable groups for 4G Clinical
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →